Steve E. Krognes Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steve E. Krognes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steve E. Krognes. Steve E. Krognes is Director in Corvus Pharmaceuticals, Inc. ($CRVS) and CFO and Treasurer in Denali Therapeutics Inc. ($DNLI) and Director in Gritstone Oncology, Inc. ($GRTS).
Latest Insider Trading Transactions of Steve E. Krognes
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRVS, DNLI, GRTS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 63.67 | 1,158 | 73,730 | 850,000 | 851.2 K to 850 K (-0.14 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.71 | 3,258 | 204,319 | 851,158 | 854.4 K to 851.2 K (-0.38 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 62.04 | 32,326 | 2,005,602 | 854,416 | 886.7 K to 854.4 K (-3.65 %) |
| Mar 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 61.16 | 13,258 | 810,912 | 886,742 | 900 K to 886.7 K (-1.47 %) |
| Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 71.43 | 400 | 28,571 | 97,587 | 98 K to 97.6 K (-0.41 %) |
| Feb 16 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.17 | 2,635 | 184,908 | 97,987 | 100.6 K to 98 K (-2.62 %) |
| Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 4,250 | 0 | 8,500 | |
| Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 75.39 | 426 | 32,116 | 12,979 | 13.4 K to 13 K (-3.18 %) |
| Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 74.38 | 1,022 | 76,018 | 13,405 | 14.4 K to 13.4 K (-7.08 %) |
| Feb 11 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 4,250 | 0 | 14,427 | 10.2 K to 14.4 K (+41.76 %) |
| Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 73.01 | 14,147 | 1,032,816 | 950,000 | 964.1 K to 950 K (-1.47 %) |
| Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 71.99 | 8,071 | 581,047 | 964,147 | 972.2 K to 964.1 K (-0.83 %) |
| Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.96 | 12,981 | 921,158 | 972,218 | 985.2 K to 972.2 K (-1.32 %) |
| Jan 20 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 70.10 | 14,801 | 1,037,535 | 985,199 | 1000 K to 985.2 K (-1.48 %) |
| Jan 06 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 70.86 | 90,000 | 6,377,400 | 90,000 | |
| Jan 06 2021 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 32.87 | 1,954 | 64,228 | 1,006,511 | 1 M to 1 M (-0.19 %) |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,008,465 | 1 M to 1 M (+0.56 %) |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 0 | |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 32.87 | 1,954 | 64,228 | 1,006,511 | 1 M to 1 M (-0.19 %) |
| Aug 24 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,008,465 | 1 M to 1 M (+0.56 %) |
| Aug 20 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Jun 22 2020 | GRTS | Gritstone Oncology ... | Krognes Steve E. | Director | Option Exercise | A | 6.66 | 12,500 | 83,250 | 12,500 | |
| Jun 12 2020 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 | |
| Apr 01 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Sell | S | 19.48 | 1,428 | 27,817 | 1,006,488 | 1 M to 1 M (-0.14 %) |
| Mar 23 2020 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 2.00 | 15,000 | 30,000 | 15,000 | |
| Feb 12 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 24.81 | 136,000 | 3,374,160 | 136,000 | |
| Feb 12 2020 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 29,143 | 0 | 29,143 | |
| Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | M | 0.00 | 5,643 | 0 | 5,643 | |
| Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Payment of Exercise | F | 18.59 | 1,977 | 36,745 | 1,003,666 | 1 M to 1 M (-0.20 %) |
| Aug 22 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | M | 0.00 | 5,643 | 0 | 1,005,643 | 1000 K to 1 M (+0.56 %) |
| Jun 24 2019 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 3.61 | 15,000 | 54,150 | 15,000 | |
| Jun 20 2019 | GRTS | Gritstone Oncology ... | Krognes Steve E. | Director | Option Exercise | A | 10.86 | 8,570 | 93,070 | 8,570 | |
| Feb 11 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 17.99 | 136,000 | 2,446,640 | 136,000 | |
| Feb 11 2019 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 17,000 | 0 | 17,000 | |
| Aug 22 2018 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 0.00 | 11,286 | 0 | 11,286 | |
| Jun 25 2018 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 12.50 | 15,000 | 187,500 | 15,000 | |
| Feb 28 2018 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | A | 22.16 | 180,000 | 3,988,800 | 180,000 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Option Exercise | C | 0.00 | 500,000 | 0 | 0 | |
| Dec 12 2017 | DNLI | Denali Therapeutic ... | Krognes Steve E. | CFO and Treasurer | Buy | C | 0.00 | 500,000 | 0 | 1,000,000 | 500 K to 1000 K (+100.00 %) |
| Mar 24 2016 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 15.00 | 30,000 | 450,000 | 30,000 |
Page: 1